Recovery from neuromuscular block and its assessment

Anesthesia and Analgesia

Volumn 90, Issue 5 SUPPL., 2000, Pages

  Bevan, David R ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Faculty of Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; EDROPHONIUM; MIVACURIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; RAPACURONIUM BROMIDE; TUBOCURARINE CHLORIDE; VECURONIUM;

ACTION POTENTIAL; ANESTHETIC RECOVERY; DOSE RESPONSE; HYPOXIA; MUSCLE WEAKNESS; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW;

EID: 0034061530     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200005001-00003     Document Type: Review

References (37)

1. Viby-Mogensen J, Jørgensen BC, Ørding H. Residual curarization in the recovery room. Anesthesiology 1979;50:539-41.
2. Lennmarken C, Löfström JB. Partial curarization in the postoperative period. Acta Anaesthesiol Scand 1984;28:260-2.
3. Beemer GH, Roxental P. Postoperative neuromuscular function. Anaesth Intensive Care 1986;14:41-5.
4. Andersen BN, Madsen JV, Schurizek BA, Juhl B. Residual curarisation: a comparative study of atracurium and pancuronium. Acta Anaesthesiol Scand 1988;32:79-81.
5. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology 1988;69:272-6.
6. Deleted in proof.
7. Baxter MRN, Bevan JC, Samuel J, et al. Post-operative neuromuscular function in pediatric day-care patients. Anesth Analg 1991;72:504-8.
8. Bevan DR, Kahwaji R, Ansermino JM, et al. Residual block after mivacurium with or without edrophonium reversal in adults and children. Anesthesiology 1996;84:362-7.
9. Berg H, Viby-Mogensen J, Roed J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiol Scand 1997;41:1095-103.
10. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Anesthesiology 1997;87:1035-43.
11. Eriksson LI, Lennmarken C, Johnson A. Attenuated ventilatory response to hypoxaemia after vecuronium induced neuromuscular block. Acta Anaesthesiol Scand 1992;36:710-5.
12. Wierda JM, van den Broek L, Proost JH, et al. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant: a comparison with succinylcholine. Anesth Analg 1993;77:579-84.
13. Ali HH, Wilson RS, Savarese JJ, Kitz RJ. The effect of d-tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth 1975;47:570-4.
14. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997;86:765-71.
15. Viby-Mogensen J. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40:59-74.
16. Drenck NE, Ueda N, Olsen NV, et al. Manual evaluation of residual curarization using Double Burst Stimulation: a comparison with train-of-four. Anesthesiology 1989;70:578-81.
17. Ansermino JM, Sanderson PM, Bevan JC, Bevan DR. Acceleromyography improves detection of residual neuromuscular blockade in children. Can J Anaesth 1996;43:569-94.
18. Baurain MJ, Hennart DA, Godschalx A, et al. Visual evaluation of residual curarization in anesthetized patients using one hundred-Herz, five-second tetanic stimulation at the adductor pollicis muscle. Anesth Analg 1998;88:185-9.
19. Baurain MJ, Hoton F, D'Hollander AA, Cantraine FR. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonise block produced by rocuronium, vecuronium, atracurium and pancuronium? Br J Anaesth 1996;77: 496-9.
20. Shorten GD, Merk H. Perioperative train-of-four monitoring and residual curarization. Can J Anaesth 1995;42:711-5.
21. Ueda N, Muteki T, Tsuda H, et al. Is the diagnosis of significant residual neuromuscular blockade improved by using double-burst stimulation. Eur J Anesth 1991;8:213-8.
22. Fruergaard K, Viby-Mogensen J, Berg H, El-Mahdy AM. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Acta Anaesthesiol Scand 1998;42:1168-74.
23. Mortensen CR, Berg H, El-Mahdy A, Viby-Mogensen J. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium Acta Anaesthesiol Scand 1995;39:797-801.
24. Bevan DR, Donati F, Kopman AF. Reversal of neuromuscular blockade. Anesthesiology 1992;77:785-805.
25. Baurain MJ, Dernovoi BS, d'Hollander AA, et al. Conditions to optimize the reversal action of neostigmine upon a vecuronium-induced neuromuscular block. Acta Anaesthesiol Scand 1996; 40:574-8.
26. Donati F, Smith CE, Bevan DR. Dose response relationships for edrophonium and neostigmine as antagonists of profound atracurium blockade. Anesth Analg 1989;68:13-9.
27. Smith CE, Donati F, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. Anesthesiology 1989;71:37-43.
28. Naguib M, Abdulatif M, Al-Ghamdi A. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (Org 9426)-induced neuromuscular blockade. Anesthesiology 1993;79:739-45.
29. Naguib M, Abdulatif M, Al-Ghamdi A, et al. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular blockade. Br J Anaesth 1993;71:709-14.
30. Meakin G, Sweet PT, Bevan JC, Bevan DR. Neostigmine and edrophonium as antagonists of pancuronium in infants and children. Anesthesiology 1983;59:316-21.
31. Fisher DM, Cronnelly R, Miller RD. Clinical pharmacology of edrophonium in infants and children. Anesthesiology 1984;61: 28-33.
32. Donati F, Smith CE, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade. Anesth Analg 1989;68:13-9.
33. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, et al. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade. Can J Anaesth 1996;43:932-8.
34. Bevan JC, Collins L, Fowler C, et al. Attempted early reversal of rocuronium and vecuronium in adults and children. Anesth Analg 1999;89:333-9.
35. Carroll MT, Mirakhur RK, Lowry D, et al. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium. Anaesthesia 1998;53:744-8.
36. Purdy R, Bevan DR, Donati F, Lichtor JL. Early reversal of rapacuronium with neostigmine. Anesthesiology 1999;91:51-7.
37. Bedford RE. From the FDA. Anesthesiology 1995;82:33A